Back to
Walleye Trading LLC
PTGX
Showing 0 of 3 quarters
Position history for
Walleye Trading LLC's holdings in PROTAGONIST THERAPEUTICS INC
No. Walleye Trading exited its PTGX (Protagonist Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 105,360 shares worth $2.4M. Walleye Trading first reported PTGX in Q4 2022 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.